scPharmaceuticals Competitors and Similar CompaniesClear all
Momenta Pharmaceuticals's competitors and similar companies include Oxurion.
 Momenta Pharmaceuticals Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. |  Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | |
Founding Date | Founding Date 2001 | Founding Date 1991 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Dublin, IE Cambridge, US | Locations Leuven, BE HQ Dublin 8, IE |
Employees | Employees 76 | Employees 785% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $23.9m (FY, 2019) | Revenue (est.) €555k (FY, 2025) |
Net income | Net income ($290.1m) (FY, 2019) | Net income (€3.7m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oxurion
HQ
Leuven, BE
Employees
78↑ 5% increase
Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company